Menu
Back to Journals » Pharmacogenomics and Personalized Medicine
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (612)
- Volume 16, 2023 (88)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Journal Articles:
- 612 records -
Identification of P3H1 as a Predictive Prognostic Biomarker for Bladder Urothelial Carcinoma Based on the Cancer Genome Atlas Database
Zhang Y, Chen Y, Chen Z, Zhou X, Chen S, Lan K, Wang Z, Zhang Y
Pharmacogenomics and Personalized Medicine 2023, 16:1041-1053
Published Date: 1 December 2023
Implication of KDR Polymorphism rs2071559 on Therapeutic Outcomes and Safety of Postoperative Patients with Gastric Cancer Who Received S-1-Based Adjuvant Chemotherapy: A Real-World Exploratory Study
Meng L, Cao J, Kang L, Xu G, Yuan DW, Li K, Zhu K
Pharmacogenomics and Personalized Medicine 2023, 16:1027-1039
Published Date: 28 November 2023
Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation
Huang R, Zhang YT, Lin Y, Pang RL, Yang Z, Zhao WH
Pharmacogenomics and Personalized Medicine 2023, 16:1011-1026
Published Date: 11 November 2023
PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
Qiao H, Li H
Pharmacogenomics and Personalized Medicine 2023, 16:991-1009
Published Date: 9 November 2023
Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review
Oliva A, Cao D, Spirito A, Nicolas J, Pileggi B, Kamaleldin K, Vogel B, Mehran R
Pharmacogenomics and Personalized Medicine 2023, 16:973-990
Published Date: 3 November 2023
Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma
Shen GY, Yang PJ, Zhang WS, Chen JB, Tian QY, Zhang Y, Han B
Pharmacogenomics and Personalized Medicine 2023, 16:959-972
Published Date: 4 November 2023
Hepatic Artery Infusion Chemotherapy Sequential Hepatic Artery Embolization Combined with Operation in the Treatment of Recurrent Massive Hepatocellular Carcinoma Achieved Pathological Complete Response: A Case Report
Chen J, Liao X, Wu Y, Ou S, Qin W, Yang C, Tan Y, Lao Q, Peng M, Peng T, Ye X
Pharmacogenomics and Personalized Medicine 2023, 16:949-958
Published Date: 1 November 2023
rs217727 of lncRNA H19 is Associated with Cervical Cancer Risk in the Chinese Han Population
Dai J, Zhang S, Shi Y, Xu J, Liu W, Yang J, Shi L, Yan Z, Li C
Pharmacogenomics and Personalized Medicine 2023, 16:933-948
Published Date: 30 October 2023
Association Between CTSK Gene Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Low Bone Mineral Density
Yuan H, Wang C, Liu L, Wang C, Zhang Z, Qu S
Pharmacogenomics and Personalized Medicine 2023, 16:925-932
Published Date: 28 October 2023
Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans
Zhou Y, Cai H, Huang L, Wang M, Liu R, Wang S, Qin Y, Yao C, Hu Z
Pharmacogenomics and Personalized Medicine 2023, 16:913-924
Published Date: 24 October 2023
A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant [Letter]
Furqoni AH, Fajarwati I, Poetranto AL
Pharmacogenomics and Personalized Medicine 2023, 16:911-912
Published Date: 25 October 2023
Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes
Mouhrach I, Bouguenouch L, Kamal A, Meriame A, El Khorb N, El Azami El Idrissi M, Akoudad H, Bekkari H
Pharmacogenomics and Personalized Medicine 2023, 16:901-909
Published Date: 2 October 2023
Homocysteine Reduction for Stroke Prevention: Regarding the Recent AHA/ASA 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Brown C, Wang J, Jiang H, Elias MF
Pharmacogenomics and Personalized Medicine 2023, 16:895-900
Published Date: 3 October 2023
Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies
Rani DS, Kasala A, Dhandapany PS, Muthusami U, Kunnoth S, Rathinavel A, Ayapati DR, Thangaraj K
Pharmacogenomics and Personalized Medicine 2023, 16:883-893
Published Date: 20 September 2023
Genome-Wide Identification of lncRNA and mRNA for Diagnosing Type 2 Diabetes in Saudi Arabia
Albogami S
Pharmacogenomics and Personalized Medicine 2023, 16:859-882
Published Date: 15 September 2023
Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation
Jarrar Y, Abudahab S, Abdul-Wahab G, Zaiter D, Madani A, Abaalkhail SJ, Abulebdah D, Alhawari H, Musleh R, Lee SJ
Pharmacogenomics and Personalized Medicine 2023, 16:847-857
Published Date: 13 September 2023
Chromosomal Copy Number Variation Predicts EGFR-TKI Response and Prognosis for Patients with Non-Small Cell Lung Cancer
He H, Ma H, Chen Z, Chen J, Wu D, Lv X, Zhu J
Pharmacogenomics and Personalized Medicine 2023, 16:835-846
Published Date: 13 September 2023
Genetic Polymorphism of NQO1 Influences Susceptibility to Coronary Heart Disease in a Chinese Population: A Cross-Sectional Study and Meta-Anaylsis
Zhou YY, Sun JH, Wang L, Cheng YY
Pharmacogenomics and Personalized Medicine 2023, 16:825-833
Published Date: 11 September 2023
A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant
Tang Q, Gong D, Ye XM, Xu JR, Yang YC, Yan LJ, Zou L, Wen XL
Pharmacogenomics and Personalized Medicine 2023, 16:817-823
Published Date: 8 September 2023
Hsa_circ_0003489 Drives PTX Resistance of Human NSCLC Cells Through Modulating miR-98-5p/IGF2
Xia S, Wang C
Pharmacogenomics and Personalized Medicine 2023, 16:805-815
Published Date: 4 September 2023
Pyroptosis and Inflammasome-Related Genes-NLRP3, NLRC4 and NLRP7 Polymorphisms Were Associated with Risk of Lung Cancer
Jing X, Yun Y, Ji X, Yang E, Li P
Pharmacogenomics and Personalized Medicine 2023, 16:795-804
Published Date: 25 August 2023
A Case-Control Study of the Relationship Between Genetic Polymorphism and Cretinism in Xinjiang
Huang J, Wu H, Zhao G, Ma Y, An Y, Sun L, Li F, Wang S
Pharmacogenomics and Personalized Medicine 2023, 16:785-794
Published Date: 23 August 2023
Clinical Characteristics and Novel ZEB2 Gene Mutation Analysis of Three Chinese Patients with Mowat-Wilson Syndrome
Han X, Zhang Q, Wang C, Han B
Pharmacogenomics and Personalized Medicine 2023, 16:777-783
Published Date: 23 August 2023
A Case Study and Literature Review of the Diagnosis of Danon Disease in Patients Presenting Only with Severe Cardiac Symptoms
Sun YQ, Lv Q, Chen D, Da Y, Zhao XY, Dong JZ
Pharmacogenomics and Personalized Medicine 2023, 16:767-775
Published Date: 17 August 2023
Identification of Two Novel Variants of the DMD Gene in Chinese Families with Duchenne Muscular Dystrophy
Wu J, Ren L, Huang X, Hu L, Zhang L, Xie D, Li Z, Han N, Huang S
Pharmacogenomics and Personalized Medicine 2023, 16:759-766
Published Date: 17 August 2023
PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
Huang W, Qian Z, Shi Y, Zhang Z, Hou R, Mei J, Xu J, Ding J
Pharmacogenomics and Personalized Medicine 2023, 16:747-758
Published Date: 9 August 2023
Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
Montrasio C, Cheli S, Clementi E
Pharmacogenomics and Personalized Medicine 2023, 16:739-746
Published Date: 27 July 2023
Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
Coons JC, Empey PE
Pharmacogenomics and Personalized Medicine 2023, 16:729-737
Published Date: 11 July 2023
Association Between HTRA1, GAS6 and IFNGR2 Gene Polymorphisms and Stroke Susceptibility in the Chinese Han Population
Zhang F, Peng H, Fu C, Deng Y, Zhang M, Li W, Zhong J, Zhou Q, Huang L, Xiao S, Zhao J
Pharmacogenomics and Personalized Medicine 2023, 16:717-727
Published Date: 7 July 2023
Impact of TREM1 Variants on the Risk and Prognosis of Glioma in the Chinese Han Population
Hu M, Wei J, Hao J, Jin T, Li B
Pharmacogenomics and Personalized Medicine 2023, 16:707-715
Published Date: 3 July 2023
Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
Bollinger A, Stäuble CK, Jeiziner C, Wiss FM, Hersberger KE, Lampert ML, Meyer zu Schwabedissen HE, Allemann SS
Pharmacogenomics and Personalized Medicine 2023, 16:693-706
Published Date: 3 July 2023
Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?
Vears DF, Savulescu J, Christodoulou J, Wall M, Newson AJ
Pharmacogenomics and Personalized Medicine 2023, 16:681-691
Published Date: 1 July 2023
Identification of Novel Prognostic Biomarkers That are Associated with Immune Microenvironment Based on GABA-Related Molecular Subtypes in Gastric Cancer
Wang B, Huang L, Ye S, Zheng Z, Liao S
Pharmacogenomics and Personalized Medicine 2023, 16:665-679
Published Date: 28 June 2023
A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps
Eken E, Estores DS, Cicali EJ, Wiisanen KK, Johnson JA
Pharmacogenomics and Personalized Medicine 2023, 16:645-664
Published Date: 23 June 2023
Integrated Bioinformatics Analysis and Experimental Verification of Immune Cell Infiltration and the Related Core Genes in Ulcerative Colitis
Zhao D, Qin D, Yin L, Yang Q
Pharmacogenomics and Personalized Medicine 2023, 16:629-643
Published Date: 23 June 2023
The Association of Methylation Level in the CYP39A1 Gene with High Altitude Pulmonary Edema in the Chinese Population
Wang P, Lu H, Rong H, Wang Y, Wang L, He X, Yuan D, He Y, Jin T
Pharmacogenomics and Personalized Medicine 2023, 16:617-628
Published Date: 21 June 2023
One Rare Warfarin Resistance Case and Possible Mechanism Exploration
Zhao L, Zhai Z, Li P
Pharmacogenomics and Personalized Medicine 2023, 16:609-615
Published Date: 20 June 2023
Genetic Variants of CYP4F2 Associated with Ischemic Stroke Susceptibility in the Han Population from Southern China
Huang K, Ma T, Li Q, Zhou Y, Qin T, Zhong Z, Tang S, Zhang W, Zhong J, Lu S
Pharmacogenomics and Personalized Medicine 2023, 16:599-607
Published Date: 15 June 2023
Exploration into Plasma Hsa_circ_0052184 as a New Biomarker of Colorectal Cancer Prognosis
Zheng E, Xiao D
Pharmacogenomics and Personalized Medicine 2023, 16:589-597
Published Date: 12 June 2023
Clinical and Gene Analysis of Fatty Acid Oxidation Disorders Found in Neonatal Tandem Mass Spectrometry Screening
Wang X, Fang H
Pharmacogenomics and Personalized Medicine 2023, 16:577-587
Published Date: 5 June 2023
Genetic Influence of Fracture Nonunion (FNU): A Systematic Review
Sadat-Ali M, Al-Omar HK, AlTabash KW, AlOmran AK, AlDakheel DA, AlSayed HN
Pharmacogenomics and Personalized Medicine 2023, 16:569-575
Published Date: 5 June 2023
Leucyl and Cystinyl Aminopeptidase as a Prognostic-Related Biomarker in OV Correlating with Immune Infiltrates
Ma Q, Chang L, Wang W, Che L, Song X, Li G, Zhang Y, Chen Y, Gu Z, Ge X
Pharmacogenomics and Personalized Medicine 2023, 16:551-568
Published Date: 2 June 2023
Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers’ Pneumoconiosis: A Case–Control Study
Hou Z, Zhang X, Gao Y, Geng J, Jiang Y, Dai H, Wang C
Pharmacogenomics and Personalized Medicine 2023, 16:537-549
Published Date: 1 June 2023
Exploring the Correlation Between GPR176, a Potential Target Gene of Gastric Cancer, and Immune Cell Infiltration
Gu X, Shen H, Xiang Z, Li X, Zhang Y, Zhang R, Su F, Wang Z
Pharmacogenomics and Personalized Medicine 2023, 16:519-535
Published Date: 1 June 2023
Mental Health Prescribers’ Perceptions on the Use of Pharmacogenetic Testing in the Management of Depression in the Middle East and North Africa Region
Aboelbaha S, Zolezzi M, Abdallah O, Eltorki Y
Pharmacogenomics and Personalized Medicine 2023, 16:503-518
Published Date: 30 May 2023
Role of CYP19A1 Loci (rs28757157 and rs3751591) with Ischemic Stroke Risk in the Chinese Han Population
Huang K, Ma T, Li Q, Zhong Z, Qin T, Zhou Y, Zhang W, Tang S, Zhong J, Lu S
Pharmacogenomics and Personalized Medicine 2023, 16:491-502
Published Date: 29 May 2023
Plasma Homocysteine (Hcy) Concentration Functions as a Predictive Biomarker of SPECT-Evaluated Post-Ischemic Hyperperfusion in Acute Ischemic Stroke
Wang Y, Hou R, Liu Y
Pharmacogenomics and Personalized Medicine 2023, 16:481-489
Published Date: 25 May 2023
Exploration and Validation of Pancreatic Cancer Hub Genes Based on Weighted Gene Co-Expression Network Analysis and Immune Infiltration Score Analysis
Li XX, Li H, Jin LQ, Tan YB
Pharmacogenomics and Personalized Medicine 2023, 16:467-480
Published Date: 22 May 2023
Giant Multilocular-Cystic Metaplastic Thymoma: A Case Report
Han L, Gao B, Wang EH, Wang L
Pharmacogenomics and Personalized Medicine 2023, 16:463-466
Published Date: 19 May 2023
The Influence of Cytochrome P450 Polymorphisms on Pharmacokinetic Profiles and Treatment Outcomes Among Malaria Patients in Sub-Saharan Africa: A Systematic Review
Marwa KJ, Kapesa A, Kamugisha E, Swedberg G
Pharmacogenomics and Personalized Medicine 2023, 16:449-461
Published Date: 18 May 2023